© John Wiley & Sons Ltd
Edited By: Editor-in-Chief: David Y Graham and Assistant Editor: Francis Megraud
Impact Factor: 3.92
ISI Journal Citation Reports © Ranking: 2015: 19/79 (Gastroenterology & Hepatology); 29/123 (Microbiology)
Online ISSN: 1523-5378
Virtual Issues from Helicobacter
Top Cited Articles,
Published: 29 Dec 2009
Prevalence and risk factors for Helicobacter pylori Infection in chinese populations
Ruihua Shi, Shunfu Xu , Hongjie Zhang , Yanbing Ding , Guiqian Sun, Xiayue Huang , Xiaoxing Chen , Xueliang Li , Zhigang Yan and Guoxin Zhang
One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin
Stephan Miehlke, Wulf Schneider-Brachert, Christian Kirsch, et al.
Helicobacter and Gastric Malignancies
António Carlos Ferreira, Hajime Isomoto, Masatsugu Moriyama, et al.
Four Modes of Adhesion are Used During Helicobacter pylori Binding to Human Mucins in the Oral and Gastric Niches
Sara K. Lindén, Claes Wickström, Gert Lindell, et al.
Epidemiology of Helicobacter pylori Infection
Michael G. Bruce and Heidi Ingrid Maaroos
NMR-Based Metabonomics for Detection of Helicobacter pylori Infection in Gerbils: Which Is More Descriptive
Xing X. Gao, Hui M. Ge, Wei F. Zheng and Ren X. Tan
CpG Island Hypermethylation of Tumor-Suppressor Genes in H. pylori-Infected Non-Neoplastic Gastric Mucosa Is Linked with Gastric Cancer Risk
Mitsuru Kaise, Takuji Yamasaki, Jin Yonezawa, Jun Miwa, Yasuhiko Ohta and Hisao Tajiri
IL-17 is Involved in Helicobacter pylori-Induced Gastric Inflammatory Responses in a Mouse Model
Satoshi Shiomi, Akihiro Toriie, Shigeyoshi Imamura, et al.
Inhibition of Helicobacter pylori Infection in Humans by Lactobacillus reuteri ATCC 55730 and Effect on Eradication Therapy: A Pilot Study
Ruggiero Francavilla , Elena Lionetti , Stefania Paola Castellaneta, et al.